Its probably too late but does anyone know for sure that it would be too late to include participants for our trial that have this new variant?  Or, does an entirely new trial have to be run, and perhaps only so once 'Mu' becomes a dominant variant?  TIA for any thoughts on this.

https://www.cnbc.com/2021/09/01/who-says-it-is-monitoring-a-new-covid-variant-called-mu.html